News & Articles

Integrated pre-clinical platform to accelerate therapeutic development

Tell us which new products have had the biggest impact on your lab work for a chance to win one of four $100 Amazon.com Gift Cards

Explore the future of membrane protein therapeutics with innovative antibody platforms

VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate

Discover how University of Copenhagen researchers are using immunoassays to unravel peptide hormone dynamics and their implications in diabetes

Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer

New and unique opportunity to advance cancer treatment

ELRIG appoints Dr. Del Trezise as Chair of the Board

Scientists at Charles River Laboratories share top tips for overcoming the challenges of designing a potency assay development strategy for advanced therapy medicinal products

Discover how humanized mouse models are revolutionizing drug safety testing, reducing toxicity risks, and paving the way for more effective therapies

Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development

Agilent, Tecan, and Cytiva among those recognized

Nucleus Biologics has received EXCiPACT certification for pharmaceutical excipients and pharmaceutical auxiliary materials (PAMs) and ISO 9001 certification from SGS

Explore CN Bio's innovative gut/liver-on-a-chip solution, empowering researchers to accurately profile human oral drug bioavailability in vitro

BioPORTER protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.

Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

Connect, collaborate, and explore crucial topics in biopharma online

Philipp Wachter discusses the potential for innovative cell culture membrane inserts to supercharge drug discovery efforts

New assay set to enhance safety and efficacy profiling in preclinical drug development

Explore trends and innovations in drug development and the vital role organizations like Alturas Analytics play in overcoming bioanalytical challenges

Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice

Innovative 3D in vitro microphysiological test systems improve the understanding of host-pathogen interactions and the evaluation of antimicrobial treatments, a potential aid in the fight against infections and resistance

Learn how the latest automated cell counting technology is enhancing autoimmune disease research at Yale School of Medicine’s Hafler Lab